Filed: 5/15/2024ACC: 0001389932-24-000012
📋 What this filing means
DAFNA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 72 equity positions with a total reported market value of $439.28M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
72
Positions
$439.28M
Total AUM (reported)
45.91M
Total Shares
Allocation by class
COM$262.05M59.7%
COM NEW$74.40M16.9%
ETF$54.98M12.5%
SPONSORED ADR$13.98M3.2%
SPONSORED ADS$8.21M1.9%
COMMON STOCK$7.38M1.7%
NOTE 2.250% 4/0$4.61M1.0%
Portfolio Concentration
Top 3$104.54M23.8%
4–10$112.81M25.7%
11–25$127.38M29.0%
Rest$94.56M21.5%
Top 3 weight
23.8%
Top 10 weight
49.5%
Voting Authority Distribution
Total shares with voting rights: 45.91M
Sole
Full voting authority
45.91M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole72
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings72
Rows:
SPDR S&P BIOTECH ETF
SOLEShares431.21K
TypeSH
Market value$40.92M
9.31%
Sole
431.21K
Shared
0.00
None
0.00
STEREOTAXIS INC
SOLEShares13.68M
TypeSH
Market value$35.71M
8.13%
Sole
13.68M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares398.10K
TypeSH
Market value$27.91M
6.35%
Sole
398.10K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares446.34K
TypeSH
Market value$19.59M
4.46%
Sole
446.34K
Shared
0.00
None
0.00
MERUS N V
SOLEShares379K
TypeSH
Market value$17.07M
3.89%
Sole
379K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares511.89K
TypeSH
Market value$16.50M
3.76%
Sole
511.89K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares194.12K
TypeSH
Market value$15.92M
3.62%
Sole
194.12K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares659.57K
TypeSH
Market value$15.70M
3.57%
Sole
659.57K
Shared
0.00
None
0.00
ISHARES NASDAQ BIOTECH INDX
SOLEShares102.50K
TypeSH
Market value$14.07M
3.20%
Sole
102.50K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares92.47K
TypeSH
Market value$13.98M
3.18%
Sole
92.47K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares273.74K
TypeSH
Market value$11.78M
2.68%
Sole
273.74K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares666.46K
TypeSH
Market value$11.01M
2.51%
Sole
666.46K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares106.76K
TypeSH
Market value$10.13M
2.31%
Sole
106.76K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares71.61K
TypeSH
Market value$9.88M
2.25%
Sole
71.61K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares806.97K
TypeSH
Market value$9.57M
2.18%
Sole
806.97K
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares258.21K
TypeSH
Market value$9.14M
2.08%
Sole
258.21K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares65.55K
TypeSH
Market value$9.09M
2.07%
Sole
65.55K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares412.66K
TypeSH
Market value$8.80M
2.00%
Sole
412.66K
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares271.03K
TypeSH
Market value$8.24M
1.88%
Sole
271.03K
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares231.75K
TypeSH
Market value$8.16M
1.86%
Sole
231.75K
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares935.89K
TypeSH
Market value$7.55M
1.72%
Sole
935.89K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares118.73K
TypeSH
Market value$6.49M
1.48%
Sole
118.73K
Shared
0.00
None
0.00
2SEVENTY BIO INC
SOLEShares1.20M
TypeSH
Market value$6.44M
1.47%
Sole
1.20M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares306.20K
TypeSH
Market value$5.59M
1.27%
Sole
306.20K
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares912.93K
TypeSH
Market value$5.50M
1.25%
Sole
912.93K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P BIOTECH ETFSOLE | ETF | 431.21K | SH | $40.92M 9.31% | 431.21K | 0.00 | 0.00 |
STEREOTAXIS INCSOLE | COM NEW | 13.68M | SH | $35.71M 8.13% | 13.68M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 398.10K | SH | $27.91M 6.35% | 398.10K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 446.34K | SH | $19.59M 4.46% | 446.34K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 379K | SH | $17.07M 3.89% | 379K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 511.89K | SH | $16.50M 3.76% | 511.89K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 194.12K | SH | $15.92M 3.62% | 194.12K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 659.57K | SH | $15.70M 3.57% | 659.57K | 0.00 | 0.00 |
ISHARES NASDAQ BIOTECH INDXSOLE | ETF | 102.50K | SH | $14.07M 3.20% | 102.50K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 92.47K | SH | $13.98M 3.18% | 92.47K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 273.74K | SH | $11.78M 2.68% | 273.74K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 666.46K | SH | $11.01M 2.51% | 666.46K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 106.76K | SH | $10.13M 2.31% | 106.76K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 71.61K | SH | $9.88M 2.25% | 71.61K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 806.97K | SH | $9.57M 2.18% | 806.97K | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | COM NEW | 258.21K | SH | $9.14M 2.08% | 258.21K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 65.55K | SH | $9.09M 2.07% | 65.55K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 412.66K | SH | $8.80M 2.00% | 412.66K | 0.00 | 0.00 |
ATRICURE INCSOLE | COM | 271.03K | SH | $8.24M 1.88% | 271.03K | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | COM | 231.75K | SH | $8.16M 1.86% | 231.75K | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 935.89K | SH | $7.55M 1.72% | 935.89K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 118.73K | SH | $6.49M 1.48% | 118.73K | 0.00 | 0.00 |
2SEVENTY BIO INCSOLE | COMMON STOCK | 1.20M | SH | $6.44M 1.47% | 1.20M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 306.20K | SH | $5.59M 1.27% | 306.20K | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 912.93K | SH | $5.50M 1.25% | 912.93K | 0.00 | 0.00 |
Page 1 of 3